Posted by Jameswarnica on July 7, 2005, at 18:51:09
In reply to Re: I WANT THIS MED TO COME OUT!!, posted by SLS on July 2, 2005, at 7:02:55
> It's too bad that drug companies don't support studies of compounds to be used as adjuncts to antidepressants in depression as they do in epilepsy. Lamictal, Neurontin, Topiramate, etc. were studied and approved by the FDA as adjuncts to other AEDs and not as monotherapy. Gepirone might serve better as an adjunct to ADs rather than as monotherapy.
>
>
> - Scott
>
> Actually, based on these two studies, I would say that Gepirone is better as its own monotherapy. They ran two studies and one was statistically significant and the other supportive. I have heard that for the SSRIs, only 1 out of 3 studies usually shows statistically significant results. Here you have 1.5 out of 2. That's impressive. Also, since one of the big positives of gepirone is the lack of side effects seen in the SSRIs, taking gepirone with an SSRI would negate this.
>
>
poster:Jameswarnica
thread:522084
URL: http://www.dr-bob.org/babble/20050702/msgs/524713.html